Daiichi Sankyo
Ming Zheng currently holds the position of Senior Director of Quantitative Clinical Pharmacology at Daiichi Sankyo, Inc., starting in February 2020. Prior to this role, Ming Zheng served at Bristol-Myers Squibb from April 2008 to February 2020, progressing from Associate Director in Clinical Pharmacology and Pharmacometrics to Director of Quantitative Clinical Pharmacology, where responsibilities included leading the PBPK group in quantitative clinical pharmacology. Ming Zheng earned a PhD in Pharmaceutical Sciences from The University of British Columbia between January 1993 and January 1997, and also received education from Shanghai Medical University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices